can retatrutide cause blood clots Tirzepatide Clots? Staying Safe STOP RETATRUTIDE? The DANGERS Of

Triple hormone receptor agonist retatrutide in obesity and diabetes management

HbA1c: Check at baseline, 6 weeks, 12 weeks, and quarterly thereafter

www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

Given previous shortages of these drugs, Mellor emphasised that it was essential that both are "given to those with the greatest need," such as people living with type 2 diabetes

Early detection and treatment of these conditions are critical to avoid serious complications

This monitoring typically includes follow-up appointments where healthcare providers assess weight changes, metabolic markers, and any side effects experienced